Form 4: Twist Bioscience Corp. COO Patrick John Finn Sells 20,000 Shares

Patrick John Finn, President and COO of Twist Bioscience Corp, sold 20,000 shares of common stock at an average price of $32.313 on May 8, 2025.

Summary

• On May 8, 2025, Patrick John Finn, the President and COO of Twist Bioscience Corp (TWST), sold 20,000 shares of the company's common stock.
• The sale was executed at a weighted average price of $32.313 per share.
• The price range for the shares sold was between $31.845 and $32.76.
• Following the transaction, Finn directly owns 242,660 shares of Twist Bioscience Corp.
• The transaction was reported on a Form 4 filing with the Securities and Exchange Commission.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating a sale of shares by a company executive. It doesn't inherently convey positive or negative sentiment, but rather reports a factual transaction. The sentiment is neutral.

Industry Context

Executive stock sales are a common occurrence and are often scrutinized by investors for insights into a company's prospects. It's important to consider the context of the sale, such as the executive's overall holdings and any stated reasons for the transaction.

Stakeholder Impact

• Shareholders may interpret the sale as a lack of confidence in the company's future prospects, although this is not necessarily the case.

Key Dates

Keywords

Form 4, TWST, Twist Bioscience, Stock Sale, Patrick John Finn, Executive, COO